Search Results - martin+rudolf

1 Results

Sort By:

2020-439 4F FOR AMD

Researchers at UCLA’s David Geffen School of Medicine, in collaboration with researchers from the University of Lubeck, Germany, have developed an anti-inflammatory, antiatherogenic peptide which ameliorates symptoms and progression of age-related macular degeneration (AMD) and could work to reduce the severity of other eye diseases presenting...

Published: 7/19/2023 | Inventor(s): Alan Fogelman, Mohamad Navab, Gattadahalli Anantharamaiah, Martin Rudolf

Keywords(s): Macular Degeneration, Peptide

Category(s): Platforms > Drug Delivery > Peptide Base